Illumina to Grow Sales Staff by At Least Half in '06; Affy Suit Could Go to Court in Early March | GenomeWeb
NEW YORK (GenomeWeb News) – Illumina’s global sales staff will increase by at least half this year as the company sets to roll out its BeadXpress molecular diagnostic platform, a company official said today.
CEO Jay Flatley, speaking to investors at the UBS Global Life Sciences Conference here today, said Illumina’s sales staff will grow by between 50 percent and 60 percent this year over last.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.